David Lanfear News Today

'Carpetbagger' Candidate [Re "Former Middlebury Selectboard Member Announces Bid for Governor," January 5, online]: A 33-year-old from Connecticut running for governor of Vermont? Are you...

/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health...

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.

The partnership could yield data to support the use of whole-genome sequencing in treating and managing cardiovascular disease, the leading cause of death in the US.

The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies for heart failure 

It may seem counterintuitive, but a new trial testing extra sodium intake in patients receiving high-dose IV diuretics for acute HF challenges routine use of salt restriction in that setting.

/PRNewswire/ -- In January 2022, a team of University of Maryland School of Medicine (UMSOM) surgeon-scientists successfully implanted a genetically modified...

This all-virtual heart failure drug assessment study could serve as a model for future research 

DETROIT (June 22, 2022) –Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed completely virtual during the

Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed completely virtual during the COVID-19 pandemic. The novel study design could serve as a model for future research.